Table of Contents

About Research

NPF is committed to leading collaborative, transformational research that leads to better treatments and a cure for these chronic diseases.

Leading Research

With the release of the 2020 – 2024 Strategic Plan, the NPF Research Team reaffirmed its commitment to lead collaborative, transformational research in psoriatic disease by defining four focus area benchmarks:

  • Generate research resulting in higher numbers of patients in remission and identify tools to extend remission periods.
  • Fund a diagnostic test for psoriatic arthritis (PsA) that has broad clinical utility, with the test having been developed, tested, and approved for use.
  • Identify a reliable, predictive model for onset of psoriatic disease, the potential relationship to comorbid conditions and the best treatment practices for a cure.
  • Establish a multi‐institution, multi‐disciplinary, team‐based, virtual cluster whose stated aim is to identify an intervention that will prevent the onset of psoriatic disease or its comorbidities.

Funding Research

NPF is the largest nonprofit funder of psoriasis and PsA research in the world. Beginning with an initial investment in 1987 through the Pilot Program award, NPF has invested over $30 million in grants and fellowships focused on psoriatic disease and related comorbidities.

NPF advances research in psoriatic disease by maintaining a robust research program, contributing almost $4 million annually to support grant and fellowship programs, including support of research efforts in line with NPF’s 2020 – 2024 Strategic Plan, such as the Psoriasis Prevention Initiative and the PsA Diagnostic Test Grant.

NPF funding focuses on ‘buckets’ of expertise – training grants, traditional grants, bridge grants, and priority research initiatives.

Training opportunities, focused on developing future psoriatic disease researchers and supporting retention of early-career researchers, include Psoriatic Disease Research Fellowships, and Summer Student Research Grants.

Traditional grant funding opportunities provide support across the expansive lifecycle of research. The road to better treatments begins with basic research that answers fundamental questions about disease mechanisms. Basic researchers ask the important fundamental questions, which lead to results that translational researchers transform into key treatments or interventions that improve patients’ lives.

Learn more about available NPF funding opportunities, discover our active research projects, or donate to our research efforts.

NPF-Led Research and Publications

As a leader in collaborative, transformational psoriatic disease research, NPF-funded researchers and NPF staff have contributed dozens of publications to the scientific record. NPF publishes the latest research for dermatologists, rheumatologists, and the community in the Journal of Psoriasis and Psoriatic Arthritis.

Empowering those living with psoriatic disease to be both the subject and the scientist, NPF runs the Citizen Pscientist project, where more than seven thousand patients have joined, sharing their experiences and insights. To more fully understand the psoriatic disease community and their areas of need, NPF conducts an Annual Survey of people affected by psoriasis and psoriatic arthritis.

In addition to supporting research through funding opportunities, NPF conducts internal research in collaboration with the NPF Scientific Advisory Committee, COVID-19 Task Force, and Medical Board, as well as research through partnerships with other institutions, such as the LITE study. NPF is preparing for the first Foundation-led clinical study, an evaluation of the effect of educational intervention on treatment outcomes.

Upcoming Events

A doctor browses documents on a tablet in an office.

Grand Rounds

NPF Grand Rounds provide overviews and updates in psoriatic disease with the ultimate goal of improving patient outcomes.

Learn more
African American female doctor and her colleague elbow bumping while wearing protective face masks at medical clinic.

Interdisciplinary Approaches to Holistic Care in Psoriatic Disease

Join us September 24 in Philadelphia! Co-Chairs Philip J. Mease, M.D. and Alexis. R Ogdie-Beatty, M.D., MSCE, have assembled an excellent group of faculty and leaders in the field to provide an in-depth training on how to manage complex cases and associated comorbid conditions while working with each other.

This program is accredited for 4.0 AMA PRA Category 1 Credits.

Register now

Latest NPF Research News

Anatomic representation of a heart

What We Know About Psoriasis and Heart Disease

A deep dive into the largest single grant investment in the history of NPF – the Psoriasis Prevention Initiative.

Read more
Image of coronavirus molecule.

NPF COVID-19 Task Force

This group of medical and scientific experts have collaborated to provide updated recommendations for people with psoriatic disease and guiding NPF in response to the pandemic and beyond.

Visit the Resource Center

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity Navigator

Copyright © 1996-2022 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.